Cinctive Capital Management LP

Position in INSM — INSMED Inc

CIK 1787258 New York, NY

Position in INSM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,272,013

+$5,324,752 QoQ

Shares Held

161,996

+121.7% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#130

of 663 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cinctive Capital Management LP holds $200,361,017 across 44 Biotechnology names. INSM ranks #2 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	350,165	$46,477,400
2	INSM	INSMED Inc This page	161,996	$17,272,013
3	VRTX	Vertex Pharmaceuticals Inc / Ma	26,712	$13,268,651
4	CYTK	Cytokinetics Inc	137,838	$11,742,419
5	ROIV	Roivant Sciences Ltd.	226,140	$8,003,094
6	NTHI	Neonc Technologies Holdings, Inc.	1,607,464	$7,281,811
7	ERAS	Erasca, Inc.	391,642	$7,174,881
8	KRYS	Krystal Biotech, Inc.	16,367	$6,083,122

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,272,013	161,996	+121.7%	Shares	Sole	2026-08-14
2026-03-31	$11,947,261	73,063	+307.1%	Shares	Sole	2026-05-15
2025-12-31	$3,123,147	17,945	-72.9%	Shares	Sole	2026-02-17
2025-09-30	$9,530,725	66,181	+101.3%	Shares	Sole	2025-11-14
2025-06-30	$3,308,439	32,874	+39.6%	Shares	Sole	2025-08-14
2025-03-31	$1,796,858	23,553	-6.7%	Shares	Sole	2025-05-15
2024-12-31	$1,743,398	25,252	-17.8%	Shares	Sole	2025-02-12
2024-09-30	$2,241,538	30,706	-78.9%	Shares	Sole	2024-11-14
2024-06-30	$9,752,319	145,557	+141.5%	Shares	Sole	2024-08-14
2024-03-31	$1,634,935	60,263	-65.6%	Shares	Sole	2024-05-15
2023-12-31	$5,423,250	175,000	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.